Customized Due Diligence

Our customized due-diligence services enable institutions to benefit from the expertise of a select team of industry authorities and their exclusive clinical, regulatory, and policy insights. As part of this service, we evaluate the:

Basic medical and scientific merits of novel products
Quality of publicly reported preclinical and clinical trial data
Outcome scenarios and probabilistic estimates of upcoming key events
Clinical trial methodology and statistical analyses
Regulatory strategy and risk
Competition
Policies affecting third-party payer coverage and market demand
Macroeconomic and political factors
Product safety in the context of overall cost-effectiveness